Search

Your search keyword '"Heijmen, B.J.M."' showing total 333 results

Search Constraints

Start Over You searched for: Author "Heijmen, B.J.M." Remove constraint Author: "Heijmen, B.J.M."
333 results on '"Heijmen, B.J.M."'

Search Results

6. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).

7. Transarterial Chemoembolization with Drug-Eluting Beads vs. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes from a Multicenter Randomized Phase II Trial

14. Stereotactic Body Radiation Therapy Following Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Feasibility Study

16. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases

17. Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer

18. The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases

19. Stereotactic Body Radiotherapy

20. Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part I: Intra-fraction breathing motion management

21. Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes

22. Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies

23. First system for fully-automated multi-criterial treatment planning for a high-magnetic field MR-Linac applied to rectal cancer

24. Online-adaptive versus robust IMPT for prostate cancer: How much can we gain?

25. Automated Radiotherapy Planning for Patient-Specific Exploration of the Trade-Off Between Tumor Dose Coverage and Predicted Radiation-Induced Toxicity-A Proof of Principle Study for Prostate Cancer

27. Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial

28. Automatic configuration of the reference point method for fully automated multi-objective treatment planning applied to oropharyngeal cancer

30. Coping with interfraction time trends in tumor setup

31. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 416 Patients with 560 Metastases

34. Automated VMAT planning for postoperative adjuvant treatment of advanced gastric cancer

35. Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study

36. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

37. Fast and robust adaptation of organs-at-risk delineations from planning scans to match daily anatomy in pre-treatment scans for online-adaptive radiotherapy of abdominal tumors

39. EP-2144: Tumor and OAR delineation variation – Dice coefficient versus dose assessed with automated planning

43. The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results

44. Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy

45. An interior-point implementation developed and tuned for radiation therapy treatment planning

46. CyberKnife with integrated CT-on-rails: System description and first clinical application for pancreas SBRT

47. Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy Automatisierte volumenmodulierte Arc-Therapieplanung für Ganzbecken-Prostatabestrahlung

48. Fully automated VMAT treatment planning for advanced-stage NSCLC patients

49. OC-0541: Automated treatment planning for prospective QA in the TRENDY randomized trial on liver-SBRT for HCC

Catalog

Books, media, physical & digital resources